09 February 2010, London, UK and Cambridge, MA: - Antisoma plc (LSE: ASM; USOTC:
ATSMY) will be announcing its interim results for the six months ended 31
December 2009 on Thursday 18 February 2010.

Enquiries:
Alison Saville
Senior Marketing and Communications Executive
Antisoma plc
+44 (0)20 3249 2144

Mark Court/Lisa Baderoon/Rebecca Skye Dietrich
Buchanan Communications
+44 (0)20 7466 5000

Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that
develops novel products for the treatment of cancer. The Company has operations
in the UK and the US. Please visitwww.antisoma.com <

http://www.antisoma.com> for
further information about Antisoma.






[HUG#1382234]







  

Investegate takes no responsibility for the accuracy of the information within the site.

The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.

     © 2012 Financial Express. All rights reserved.